Biocon leads India’s push into blockbuster weight-loss drugs as patents for Saxenda, Wegovy and Ozempic set to expire | Mint – Mint

Biocon leads India’s push into blockbuster weight-loss drugs as patents for Saxenda, Wegovy and Ozempic set to expire | Mint  Mint